Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Well-Differentiated Thyroid Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01089335
What this trial is testing

Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia

Who this might be right for
Thyroid NeoplasmsThyroid Cancer
Region Skane 100
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Not applicableStudy completedNCT01341886
What this trial is testing

Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer

Who this might be right for
Malignant Neoplasm of Thyroid Stage IMalignant Neoplasm of Thyroid Stage II
Mashhad University of Medical Sciences 51
Not applicableLooking for participantsNCT06431620
What this trial is testing

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Who this might be right for
Recombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University 15
Not applicableUnknownNCT04354324
What this trial is testing

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Cancer
Zhujiang Hospital 254
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Not applicableActive Not RecruitingNCT03794375
What this trial is testing

Primary Care Transfer for Thyroid Cancer Patients

Who this might be right for
Differentiated Thyroid Cancer
Hospital de Clinicas de Porto Alegre 206
Large-scale testing (Phase 3)Study completedNCT04971473
What this trial is testing

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 201
Not applicableStudy completedNCT04522570
What this trial is testing

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Who this might be right for
Thyroid NeoplasiaWell-Differentiated Thyroid CancerMedullary Thyroid Cancer+1 more
Instituto do Cancer do Estado de São Paulo 84
Testing effectiveness (Phase 2)Study completedNCT00061906
What this trial is testing

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT05783323
What this trial is testing

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Early research (Phase 1)Study completedNCT05275946
What this trial is testing

Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Osaka University 11
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Not applicableEnded earlyNCT00926978
What this trial is testing

Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03914300
What this trial is testing

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaPoorly Differentiated Thyroid Gland Carcinoma+6 more
National Cancer Institute (NCI) 11
Not applicableStudy completedNCT05078853
What this trial is testing

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid CancerLymph Node Metastases
Soroka University Medical Center 250
Large-scale testing (Phase 3)Active Not RecruitingNCT03570021
What this trial is testing

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Gustave Roussy, Cancer Campus, Grand Paris 352
Not applicableEnded earlyNCT02947399
What this trial is testing

Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT06458036
What this trial is testing

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Next Page